30.06.2017 Views

next-generation-sequencing-ngs-market-5Bplatforms-illumina-hiseq-miseq-life-technologies-ion-proton2Fpgm-454-roche-bioinformatics-rna-seq-chip-seq-pyrosequencing-sbs-smrt-diagnostics-personalized-medi-24marketrepo

This report provided by 24 market reports is about,The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms.

This report provided by 24 market reports is about,The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Report Title:<br />

Next Generat<strong>ion</strong> Sequencing (NGS) Market<br />

[Platforms (Illumina HiSeq, MiSeq, Life Technologies<br />

Ion Proton/PGM, <strong>454</strong> Roche), Bioinformatics (RNA-<br />

Seq, ChIP-Seq), (Pyro<strong><strong>seq</strong>uencing</strong>, SBS, SMRT),<br />

(Diagnostics, Personalized Medicine)] – Global<br />

Forecast to 2017<br />

Published On: December 2016<br />

Pages: 350<br />

Category: Life Sciences<br />

Report Overview:<br />

The <strong>next</strong> <strong>generat<strong>ion</strong></strong> <strong><strong>seq</strong>uencing</strong> <strong>market</strong> is rapidly evolving with a large number of<br />

developments taking place to increase accuracy and speed, and reduce costs of <strong><strong>seq</strong>uencing</strong>. It<br />

is the fastest-growing and most lucrative segment in the genomics space with an estimated<br />

growth of 16.3%. The global NGS <strong>market</strong> was valued at $1.3 bill<strong>ion</strong> in 2012 and is poised to<br />

reach $2.7 bill<strong>ion</strong> by 2017. By supporting genomics research, various government bodies like<br />

NHGRI (Nat<strong>ion</strong>al Human Genome Research Institute, U.S.) and Biotechnology and Biological<br />

Sciences Research Council (BBSRC, U.K.) are increasing the adopt<strong>ion</strong> of high-throughput<br />

<strong><strong>seq</strong>uencing</strong> platforms.<br />

The growth of the overall NGS <strong>market</strong> is driven by continuous innovat<strong>ion</strong>s and developments in<br />

the <strong>market</strong> aimed at higher throughput, increased accuracy, and affordable costs. However,<br />

factors such as high reliability on grants and funding from the government, and decrease in<br />

capital expenditure from academic institut<strong>ion</strong>s are hindering the growth of the <strong>market</strong>. In<br />

addit<strong>ion</strong>, the interpretat<strong>ion</strong> of big data generated by <strong>seq</strong>uencers and the sub<strong>seq</strong>uent storage<br />

and management of the analyzed data is still a challenge. Owing to the complexity of NGS<br />

<strong>technologies</strong> and data, standardizat<strong>ion</strong> of the overall NGS workflow presents an unmet need.<br />

The opportunities for the growth of this <strong>market</strong> include developments in the pre-<strong><strong>seq</strong>uencing</strong>,<br />

cloud computing, and NGS <strong>bioinformatics</strong> solut<strong>ion</strong>s.<br />

The NGS platforms <strong>market</strong> was dominated by Illumina in 2012, which accounted for the largest<br />

<strong>market</strong> share of 56%. Other companies with commercial platforms include Life Technologies<br />

(U.S.), <strong>454</strong> Roche (U.S.), and Pacific Biosciences (U.S.). The recently introduced Bench-top and<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


NGS platforms will drive the <strong>market</strong>. Based on steps in the NGS workflow, the overall NGS<br />

<strong>market</strong> has three major segments, namely, pre-<strong><strong>seq</strong>uencing</strong>, NGS platforms and services, and<br />

NGS data analysis, storage and management.<br />

The raw <strong><strong>seq</strong>uencing</strong> data generated by today’s <strong>seq</strong>uencers does not reflect on any meaningful<br />

informat<strong>ion</strong> in itself. Also, open source tools for analyzing NGS data require adequate<br />

<strong>bioinformatics</strong> training. These factors open up huge opportunities for commercial NGS<br />

<strong>bioinformatics</strong> software, workbenches, and services, whose <strong>market</strong> is currently fragmented<br />

and has a relatively smaller size. Whole genome <strong><strong>seq</strong>uencing</strong>, targeted re-<strong><strong>seq</strong>uencing</strong>, de novo<br />

<strong><strong>seq</strong>uencing</strong>, RNA-Seq, ChIP-Seq and methyl-Seq are the major applicat<strong>ion</strong>s that use NGS data<br />

analysis tools and services. Key players like CLC bio (Denmark), Biomatters (New Zealand),<br />

Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.) dominate this <strong>market</strong><br />

space.<br />

Next <strong>generat<strong>ion</strong></strong> <strong><strong>seq</strong>uencing</strong> is set to revolut<strong>ion</strong>ize applied <strong>market</strong>s like <strong>diagnostics</strong>, drug<br />

discovery, biomarker discovery, <strong>personalized</strong> <strong>medi</strong>cine, and agriculture and animals research.<br />

Research institutes and government bodies contribute the highest to the end-user <strong>market</strong> of<br />

NGS; however, the adopt<strong>ion</strong> rate in hospitals will increase in the near future due to cost<br />

effectiveness, high throughput, and sensitivity.<br />

The NGS <strong>market</strong> will witness a whole new <strong>generat<strong>ion</strong></strong> of <strong><strong>seq</strong>uencing</strong> platforms based on<br />

nanapore <strong><strong>seq</strong>uencing</strong> technology and fully integrated instruments that could perform all the<br />

NGS workflow steps.<br />

Scope of the Report<br />

This research report categorizes and analyzes the global NGS <strong>market</strong> on the basis of steps in<br />

the NGS workflow and NGS applicat<strong>ion</strong>s. These <strong>market</strong>s are further divided into segments and<br />

sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and<br />

forecast to 2017. Each <strong>market</strong> is comprehensively analyzed at a granular level by geography<br />

(North America, Europe, Asia, and Rest of the World) to provide in-depth informat<strong>ion</strong> on the<br />

global scenario.<br />

Global NGS <strong>market</strong>, by steps in workflow<br />

Pre-<strong><strong>seq</strong>uencing</strong> Products and Services<br />

DNA fragmentat<strong>ion</strong> and size select<strong>ion</strong><br />

Library preparat<strong>ion</strong><br />

Target enrichment<br />

Quality control<br />

Sequencing Platforms, Consumables/Reagents and Services<br />

Illumina<br />

HiSeq Series<br />

Genome Analyzer IIx<br />

HiScanSQ<br />

MiSeq<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


Life Technologies<br />

SOLiD Series<br />

Ion PGM (Personal Genome Machine)<br />

Ion Proton<br />

<strong>454</strong> Lifesciences (Roche)<br />

GS Junior<br />

GS FLX+<br />

Pacific Biosciences<br />

PacBio RS II<br />

Others<br />

Sequencing Services<br />

NGS Data Analysis/Bioinformatics<br />

By product<br />

NGS data analysis software and workbenches<br />

NGS data analysis services<br />

NGS storage management and cloud computing solut<strong>ion</strong>s<br />

By applicat<strong>ion</strong><br />

Whole Genome Sequencing<br />

Targeted Re<strong><strong>seq</strong>uencing</strong><br />

De novo Sequencing<br />

RNA-Seq<br />

ChIP-Seq<br />

Methyl-Seq<br />

Others<br />

Global NGS <strong>market</strong>, by Technology<br />

Sequencing by synthesis (SBS)<br />

Ion semiconductor <strong><strong>seq</strong>uencing</strong><br />

Sequencing by ligat<strong>ion</strong> (SBL)<br />

Pyro<strong><strong>seq</strong>uencing</strong><br />

Single molecule, real-time (SMRT) Sequencing<br />

Global NGS <strong>market</strong>, by Applicat<strong>ion</strong><br />

Diagnostics<br />

Drug Discovery<br />

Biomarker Discovery<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


Personalized Medicine<br />

Agriculture and Animal Research<br />

Others<br />

NGS <strong>market</strong>, by Geography<br />

North America<br />

Europe<br />

Asia<br />

RoW (Africa, LATAM, Middle-East, Pacific countries)<br />

Table of Contents:<br />

Table Of Contents<br />

1 Introduct<strong>ion</strong> (Page No. - 24)<br />

1.1 Key Take-Aways<br />

1.2 Report Descript<strong>ion</strong><br />

1.3 Markets Covered<br />

1.4 Stakeholders<br />

1.5 Research Methodology<br />

1.5.1 Market Size<br />

1.5.2 Market Share<br />

1.5.3 Key Data Points From Secondary Sources<br />

1.5.4 Key Data Points From Primary Sources<br />

1.5.5 Assumpt<strong>ion</strong>s<br />

2 Executive Summary (Page No. - 33)<br />

3 Market Overview (Page No. - 38)<br />

3.1 Introduct<strong>ion</strong><br />

3.2 Evolut<strong>ion</strong><br />

3.3 Market Segmentat<strong>ion</strong><br />

3.4 Market Dynamics<br />

3.4.1 Drivers<br />

3.4.1.1 Cost and Speed to Drive the Growth of NGS Technology<br />

3.4.1.2 Substitut<strong>ion</strong> of Microarray Technology by NGS to Boost Market Growth<br />

3.4.1.3 Embracement of NGS Technology by New Consumers to Propel the Market<br />

3.4.1.4 Increase in Practice for New Scientific Applicat<strong>ion</strong>s to Boost the Growth<br />

3.4.1.5 Research Laboratories and Academicians Promoting the Use of NGS<br />

3.4.2 Restraints<br />

3.4.2.1 High Reliability on Grants to Restrict Growth<br />

3.4.2.2 Decrease in Capital Expenditure from Academic Institutes to Hinder the Sale of<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


Platforms<br />

3.4.2.3 Accuracy & Standardizat<strong>ion</strong>, a Concern in Diagnostic Testing<br />

3.4.3 Opportunities<br />

3.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for Investments in NGS<br />

Technology<br />

3.4.3.2 Pre-<strong><strong>seq</strong>uencing</strong>, a High Growth Opportunity<br />

3.4.3.3 Cloud Computing, a Prospective Service<br />

3.4.4 Challenges<br />

3.4.4.1 Interpretat<strong>ion</strong> of Complex Data from NGS Platforms<br />

3.4.4.2 Designing of Sequencers as the Breadth of NGS Applicat<strong>ion</strong>s Increase<br />

3.4.5 Market Trend<br />

3.4.5.1 Shift of Focus Towards Third Generat<strong>ion</strong> Sequencing<br />

3.4.6 Burning Issues<br />

3.4.6.1 Data Storage, an Impediment for NGS Sequencing<br />

3.4.6.2 Reduct<strong>ion</strong> in Cost to Sequence Human Genomes<br />

3.4.7 Winning Imperative<br />

3.4.7.1 Improved Collaborative Ties Between Industry and Academic & Research Institutes<br />

3.5 Porter’s Five Forces Analysis<br />

3.5.1 Threat From New Entrants<br />

3.5.2 Threat From Substitutes<br />

3.5.3 Bargaining Power Of Buyers<br />

3.5.4 Bargaining Power Of Suppliers<br />

3.5.5 Competitive Rivalry Among Exisiting Firms<br />

3.6 Value Chain<br />

3.7 Technological Development Road-Map<br />

3.7.1 Sanger Sequencing<br />

3.7.2 Massively Parallel Sequencing (Next Generat<strong>ion</strong> Sequencing)<br />

3.7.3 Single Molecule Real Time (SMRT) Sequencing<br />

3.7.4 Nanopore Sequencing<br />

3.8 Technological Trends<br />

3.8.1 Nanopore Sequencing Technology<br />

3.8.1.1 Oxford Nanopore Technologies<br />

3.8.1.2 Genia Technologies<br />

3.8.1.3 Electronic Biosciences<br />

3.8.2 Sequencing By Hybridizat<strong>ion</strong> Technology (GNUBIO)<br />

3.8.3 GENIUS (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (GENAPSYS)<br />

3.8.4 Lightning Terminator Sequencing Technology (LASERGEN)<br />

3.8.5 Optical Nanopore Sequencing Technology (NOBLEGEN)<br />

3.8.6 Nanowire Biosensor Sequencing Technology (QUANTUMDX)<br />

3.9 End-User Analysis<br />

3.9.1 Introduct<strong>ion</strong><br />

3.9.2 Research Centers, Academic & Government Institutes<br />

3.9.2.1 NGS is a Research Driven Market, Hence the Highest Market Share<br />

3.9.3 Hospitals & Clinics<br />

3.9.3.1 Hospitals and Clinics to Grow at the Fastest Rate<br />

3.9.4 Pharmaceutical & Biotechnology Companies<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


3.9.4.1 Targeted Therapy and Biomarker Research to Boost the Pharmaceutical &<br />

Biotechnology NGS Market<br />

3.9.5 Others<br />

3.10 Market Share Analysis<br />

3.10.1 Total Ngs Market<br />

3.10.1.1 Global<br />

3.10.1.2 North America<br />

3.10.1.3 Europe<br />

3.10.1.4 Asia<br />

3.10.2 NGS Platform Market<br />

3.10.2.1 Global<br />

3.10.2.2 North America<br />

3.10.2.3 Europe<br />

3.10.2.4 Asia<br />

3.10.3 NGS Bioinformatics/Data Analysis Market<br />

3.10.3.1 Global<br />

4 Global Ngs Market, By Steps In Workflow (Page No. - 78)<br />

4.1 Introduct<strong>ion</strong><br />

4.2 Pre-Sequencing Products & Services Market<br />

4.2.1 Sample Preparat<strong>ion</strong><br />

4.2.1.1 Dna Fragmentat<strong>ion</strong>, End Repair, A-Tailing And Size Select<strong>ion</strong><br />

4.2.1.2 Library Preparat<strong>ion</strong><br />

4.2.1.3 Target Enrichment<br />

4.2.1.4 Quality Control<br />

4.3 Sequencing Platforms Market<br />

4.3.1 Illumina<br />

4.3.1.1 Hi<strong>seq</strong> Series<br />

4.3.1.2 Genome Analyzer IIx<br />

4.3.1.2.1 No Technological Advancements Will Result Into Downfall Of GA IIx<br />

4.3.1.3 HiScanSQ<br />

4.3.1.4 MiSeq<br />

4.3.1.4.1 MiSeq will grow at the fastest pace amo<strong>ngs</strong>t all the platforms<br />

4.3.2 Life Technologies<br />

4.3.2.1 SOLiD Series<br />

4.3.2.1.1 Solid Series Shows Minimal Scope For Growth<br />

4.3.2.2 Ion Torrent Platforms<br />

4.3.2.2.1 Ion PGM<br />

4.3.2.2.1.1 Currently Ion PGM exceeds the unit sales as compared to its competitors<br />

4.3.2.2.2 Ion Proton<br />

4.3.2.2.2.1 Ion Proton will be one of the fast growing platforms<br />

4.3.3 <strong>454</strong> ROCHE<br />

4.3.3.1 GS Junior and GS FLX+ will Grow at Slow Pace in the Coming Years<br />

4.3.3.2 GS Junior<br />

4.3.3.3 GS FLX+<br />

4.3.4 Pacific Biosciences<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


4.3.4.1 PacBio RS II<br />

4.3.5 Others<br />

4.4 Sequencing Services Market<br />

4.5 NGS Data Analysis, Storage And Management (Bioinformatics) Market<br />

4.5.1 Open Source Applicat<strong>ion</strong>s Contribute 75% To The Overall Ngs Bioinformatics Solut<strong>ion</strong>s<br />

4.5.2 NGS Data Analysis, By Product<br />

4.5.2.1 NGS Data Analysis Software and Workbenches<br />

4.5.2.2 NGS Data Analysis Services<br />

4.5.3 NGS Data Analysis, By Applicat<strong>ion</strong><br />

4.5.3.1 Whole Genome Sequencing<br />

4.5.3.2 Targeted Re-<strong><strong>seq</strong>uencing</strong><br />

4.5.3.3 DE NOVO Sequencing<br />

4.5.3.4 RNA-Seq<br />

4.5.3.5 CHIP-Seq<br />

4.5.3.6 Methyl-Seq<br />

4.5.3.7 Others<br />

4.5.4 NGS Storage, Management & Cloud Computing Solut<strong>ion</strong>s<br />

5 NGS Technology Market (Page No. - 129)<br />

5.1 Introduct<strong>ion</strong><br />

5.2 Sequencing By Synthesis (SBS)<br />

5.2.1 SBS To Be The Fastest-Growing Technology<br />

5.3 ION Semiconductor Sequencing<br />

5.3.1 ION Semiconductor Sequencing, A Fast-Growing Market<br />

5.4 Sequencing By Ligat<strong>ion</strong> (SBL)<br />

5.4.1 SBL Technology To Witness Negative Growth<br />

5.5 Pyro<strong><strong>seq</strong>uencing</strong><br />

5.5.1 Pyro<strong><strong>seq</strong>uencing</strong> To Grow At Slow Rate<br />

5.6 Single-Molecule Real-Time Sequencing (SMRT)<br />

5.6.1 SMRT Technology Has Limited Applicat<strong>ion</strong>s<br />

6 Global NGS Applicat<strong>ion</strong> Market (Page No. - 141)<br />

6.1 Introduct<strong>ion</strong><br />

6.2 Diagnostics<br />

6.2.1 Diagnostic Market Will Grow With Addit<strong>ion</strong> Of Wider Applicat<strong>ion</strong>s<br />

6.2.2 Cancer Diagnostics To Drive the Market<br />

6.3 Drug Discovery<br />

6.3.1 Focus On Targeted Therapy To Boost The Ngs Market<br />

6.4 Biomarker Discovery<br />

6.4.1 Biomarker Discovery Applicat<strong>ion</strong> To Grow At A High Rate<br />

6.5 Personalized Medicine<br />

6.5.1 Personalized Medicine Offers Huge Potential Market<br />

6.6 Agriculture & Animal Research<br />

6.6.1 Applicat<strong>ion</strong>s In Crop Research & Animal Biotechnology To Boost The NGS Market<br />

6.7 Other Applicat<strong>ion</strong>s<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


7 Geographic Analysis (Page No. -156)<br />

7.1 Introduct<strong>ion</strong><br />

7.2 North America<br />

7.2.1 Funding By Government Agencies To Boost THE U.S. MARKET<br />

7.2.2 Canadian Government Strive To Boost NGS Market<br />

7.3 Europe<br />

7.3.1 Germany Holds The Largest Share Of European NGS Market<br />

7.3.2 U.K. To Contribute Substantially To Europe<br />

7.4 Asia<br />

7.4.1 China & Other Nat<strong>ion</strong>s Focus On Research In NGS<br />

7.4.2 Regular Funding From Indian Government, An Impetus To The Ngs Market<br />

7.5 Rest Of The World (ROW)<br />

8 Competitive Landscape (Page No. - 186)<br />

8.1 Introduct<strong>ion</strong><br />

8.1.1 New Product Launch & Agreements And Partnerships, Highly Adopted Strategies For<br />

Growth<br />

8.2 Mergers & Acquisit<strong>ion</strong>s<br />

8.3 Agreements, Partnerships, Collaborat<strong>ion</strong>s & Joint Ventures<br />

8.4 New Product Launch<br />

8.5 Expans<strong>ion</strong><br />

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*<br />

(Page No. - 236)<br />

9.1 <strong>454</strong> Life Sciences Corporat<strong>ion</strong> (A Roche Company)<br />

9.2 Agilent Technologies, Inc.<br />

9.3 BGI (Beijing Genomics Institute)<br />

9.4 Biomatters, Ltd.<br />

9.5 CLC Bio<br />

9.6 Dnastar, Inc.<br />

9.7 EMC Corporat<strong>ion</strong><br />

9.8 GATC biotech AG<br />

9.9 Genomatix Software GMBH<br />

9.10 Illumina, Inc.<br />

9.11 Knome, Inc.<br />

9.12 Life Technologies Corporat<strong>ion</strong><br />

9.13 Macrogen, Inc.<br />

9.14 Ocimum Biosolut<strong>ion</strong>s, Ltd.<br />

9.15 Oxford Nanorpore Technologies, Ltd.<br />

9.16 Pacific Biosciences<br />

9.17 Partek Incorporated<br />

9.18 Perkinelmer, Inc.<br />

9.19 Qiagen N.V.<br />

9.20 Strand Life Sciences Pvt. Ltd.<br />

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


case of unlisted companies.<br />

List of Tables (87 Tables)<br />

Table 1 Global Overall NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 2 Comparison Between Next Generat<strong>ion</strong> Sequencing & Microarray<br />

Table 3 Global NGS Market, By End-User, 2012 – 2017 ($Mill<strong>ion</strong>)<br />

Table 4 Global Overall NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 5 Overall NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 6 Global Pre-Sequencing Market, By Process,2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 7 Pre-Sequencing Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 8 Global NGS Product Market, By Company Brand, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 9 Illumina NGS Platform Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 10 Illumina NGS Consumables/Reagents Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 11 Illumina NGS Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 12 Hi<strong>seq</strong> Series Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>) 94<br />

Table 13 Genome Analyzer Iix Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 14 Hiscansq Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 15 Mi<strong>seq</strong> Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 16 Life Technologies NGS Platform Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 17 Life Technologies NGS Consumables/Reagents Market, By Geography, 2010 – 2017<br />

($Mill<strong>ion</strong>)<br />

Table 18 Life Technologies NGS Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 19 Solid Series Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 20 Ion Pgm Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 21 Ion Proton Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 22 <strong>454</strong> Roche NGS Platform Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 23 <strong>454</strong> Roche NGS Consumables/Reagents Market, By Geography, 2010 – 2017<br />

($Mill<strong>ion</strong>)<br />

Table 24 <strong>454</strong> Roche NGS Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 25 GS Junior Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 26 GS FLX+ Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 27 Pacific Biosciences NGS Platform Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 28 Pacific Biosciences NGS Consumables/Reagents Market, By Geography, 2010 – 2017<br />

($Mill<strong>ion</strong>)<br />

Table 29 Pacific Biosciences NGS Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 30 Pacbio Rs Ii Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 31 NGS Sequencing Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 32 Global NGS Data Analysis Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 33 NGS Data Analysis Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 34 NGS Data Analysis Software & Workbenches Market, By Geography, 2010 – 2017<br />

($Mill<strong>ion</strong>)<br />

Table 35 Global NGS Data Analysis Software & Workbenches Market, By Applicat<strong>ion</strong>, 2010 –<br />

2017 ($Mill<strong>ion</strong>)<br />

Table 36 NGS Data Analysis Services Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 37 Global NGS Data Services Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


Table 38 Global NGS Data Analysis Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 39 Global NGS Technology, By Company<br />

Table 40 Global NGS Market, By Technology, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 41 SBS Technology Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 42 Ion Semiconductor Sequencing Technology Market, By Geography, 2010 – 2017<br />

($Mill<strong>ion</strong>)<br />

Table 43 SBL Technology Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 44 Pyro<strong><strong>seq</strong>uencing</strong> Technology Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 45 SMRT Technology Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 46 Global NGS Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 47 Diagnostics NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 48 Drug Discovery NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 49 Biomarker Discovery NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 50 Personalized Medicine NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 51 Agriculture & Animal Research NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 52 Other Applicat<strong>ion</strong>s NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 53 NGS Pre<strong><strong>seq</strong>uencing</strong> Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 54 NGS Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 55 NGS Bioinformatics Market, By Geography, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 56 North America: NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 57 North America: NGS Product Market, By Company Brand, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 58 North America: NGS Market, By Technology, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 59 North America: NGS Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 60 North America: NGS Bioinformatics Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 61 Europe: NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 62 Europe: NGS Product Market, By Company Brand, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 63 Europe: NGS Market, By Technology, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 64 Europe: NGS Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 65 Europe: NGS Bioinformatics Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 66 Asia: NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 67 Asia: NGS Product Market, By Company Brand, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 68 Asia: NGS Market, By Technology, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 69 Asia: NGS Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 70 Asia: NGS Bioinformatics Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 71 Row: NGS Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 72 Row: NGS Product Market, By Company Brand, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 73 Row: NGS Market, By Technology, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 74 Row: NGS Market, By Applicat<strong>ion</strong>, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 75 Row: NGS Bioinformatics Market, By Product, 2010 – 2017 ($Mill<strong>ion</strong>)<br />

Table 76 Mergers & Acquisit<strong>ion</strong>s, 2011 – 2013)<br />

Table 77 Agreements, Partnerships, Collaborat<strong>ion</strong>s, Contracts & Joint Ventures, 2011 – 2013<br />

Table 78 New Product Launch, 2011 – 2013<br />

Table 79 Expans<strong>ion</strong>, 2011 – 2013<br />

Table 80 ROCHE: Total Revenue, By Segment 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 81 Agilent Technologies, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 82 EMC Corporat<strong>ion</strong>: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


Table 83 Illumina, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 84 Life Technologies Corporat<strong>ion</strong>: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 85 Pacific Biosciences Of California: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 86 Perkinelmer, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

Table 87 Qiagen N.V.: Total Revenue, By Segment, 2010 – 2012 ($Mill<strong>ion</strong>)<br />

List Of Figures (24 Figures)<br />

Figure 1 Opportunity Matrix: Global NGS Market, By Product, 2012<br />

Figure 2 NGS Market, By Geography, 2010 – 2017<br />

Figure 3 Evolut<strong>ion</strong> Of Genetic Analysis<br />

Figure 4 Market Segmentat<strong>ion</strong> Of Next Generat<strong>ion</strong> Sequencing (NGS)<br />

Figure 5 Market Dynamics Of Next Generat<strong>ion</strong> Sequencing (NGS)<br />

Figure 6 Data Storage & Pricing, 1990 – 2012<br />

Figure 7 Value Chain Analysis For Sequencing Platforms<br />

Figure 8 Global NGS Market, End-User Analysis, 2012 & 2017<br />

Figure 9 Global NGS Market Share Analysis, By Key Players, 2012 & 2017<br />

Figure 10 North America: NGS Market Share Analysis, By Key Player, 2012<br />

Figure 11 Europe: NGS Market Share Analysis, By Key Player, 2012<br />

Figure 12 Asia: NGS Market Share Analysis, By Key Player, 2012<br />

Figure 13 Global NGS Platform Market Share Analysis, By Key Player, 2012<br />

Figure 14 North America: NGS Platform Market Share Analysis, By Key Player, 2012<br />

Figure 15 Europe: NGS Platform Market Share Analysis, By Key Players, 2012<br />

Figure 16 Asia: NGS Platform Market Share Analysis, By Key Player, 2012<br />

Figure 17 Global NGS Bioinformatics Market Share Analysis, By Key Player, 2012<br />

Figure 18 Global Overall NGS Market, Product Market Share, 2010 – 2017 (%)<br />

Figure 19 Global NGS Platform Market, By Company Brand, 2012 & 2017 ($Mill<strong>ion</strong>)<br />

Figure 20 Global NGS Platform Market, Growth Rate Comparison, 2012 – 2017<br />

Figure 21 Opportunity Matrix: Global NGS Technology Market, 2012<br />

Figure 22 Global NGS Applicat<strong>ion</strong> Market, 2012 & 2017<br />

Figure 23 Key Growth Strategies, 2011 – 2013<br />

Figure 24 Key Players Focusing On New Product Launch, 2011 – 2013<br />

Get More Informat<strong>ion</strong> about the Report:<br />

Report URL:<br />

https://www.24<strong>market</strong>reports.com/mr-admin/<strong>life</strong>-sciences/<strong>next</strong>-<strong>generat<strong>ion</strong></strong>-<strong><strong>seq</strong>uencing</strong>-<strong>ngs</strong>-mar<br />

ket-<strong>5Bplatforms</strong>-<strong>illumina</strong>-<strong>hi<strong>seq</strong></strong>-<strong>mi<strong>seq</strong></strong>-<strong>life</strong>-<strong>technologies</strong>-<strong>ion</strong>-<strong>proton2Fpgm</strong>-<strong>454</strong>-<strong>roche</strong><strong>bioinformatics</strong>-<strong>rna</strong>-<strong>seq</strong>-<strong>chip</strong>-<strong>seq</strong>-pyro<strong><strong>seq</strong>uencing</strong>-<strong>sbs</strong>-<strong>smrt</strong>-<strong>diagnostics</strong>-<strong>personalized</strong><strong>medi</strong>cine5D-96-global-forecast-to-2017-<br />

To get Report Sample:<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com


https://www.24<strong>market</strong>reports.com/mr-admin/request-sample/<strong>next</strong>-<strong>generat<strong>ion</strong></strong>-<strong><strong>seq</strong>uencing</strong>-<strong>ngs</strong><strong>market</strong>-<strong>5Bplatforms</strong>-<strong>illumina</strong>-<strong>hi<strong>seq</strong></strong>-<strong>mi<strong>seq</strong></strong>-<strong>life</strong>-<strong>technologies</strong>-<strong>ion</strong>-<strong>proton2Fpgm</strong>-<strong>454</strong>-<strong>roche</strong><strong>bioinformatics</strong>-<strong>rna</strong>-<strong>seq</strong>-<strong>chip</strong>-<strong>seq</strong>-pyro<strong><strong>seq</strong>uencing</strong>-<strong>sbs</strong>-<strong>smrt</strong>-<strong>diagnostics</strong>-<strong>personalized</strong><strong>medi</strong>cine5D-96-global-forecast-to-2017-<br />

24<strong>market</strong>reports | Inte<strong>rna</strong>t<strong>ion</strong>al +1 646 781 7170 | www.24<strong>market</strong>reports.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!